Moomoo AI 已提取核心訊息
On January 23, 2024, John C. Jacobs, President and CEO of Novavax Inc (NVAX), completed a stock transaction involving the company's common stock. Jacobs exercised options to acquire 83,197 shares. On the same day, he sold 40,093 shares at a price of $4.26 per share, resulting in a total market value of $170,796.18 for the disposed shares. Following these transactions, Jacobs's direct holdings in Novavax common stock amounted to 43,104 shares.
On January 23, 2024, John C. Jacobs, President and CEO of Novavax Inc (NVAX), completed a stock transaction involving the company's common stock. Jacobs exercised options to acquire 83,197 shares. On the same day, he sold 40,093 shares at a price of $4.26 per share, resulting in a total market value of $170,796.18 for the disposed shares. Following these transactions, Jacobs's direct holdings in Novavax common stock amounted to 43,104 shares.
2024年1月23日，諾瓦瓦克斯公司（NVAX）總裁兼首席執行官約翰·雅各布斯完成了一項涉及該公司普通股的股票交易。雅各布斯行使期權收購了83,197股股票。同一天，他以每股4.26美元的價格出售了40,093股股票，使已處置股票的總市值達到170,796.18美元。這些交易之後，雅各布斯直接持有的Novavax普通股爲43,104股。
2024年1月23日，諾瓦瓦克斯公司（NVAX）總裁兼首席執行官約翰·雅各布斯完成了一項涉及該公司普通股的股票交易。雅各布斯行使期權收購了83,197股股票。同一天，他以每股4.26美元的價格出售了40,093股股票，使已處置股票的總市值達到170,796.18美元。這些交易之後，雅各布斯直接持有的Novavax普通股爲43,104股。
有用
沒用